A postmortem investigation conducted with tissue from AD and mixed dementia patients indicated that EV biogenesis was altered during the preclinical stage of AD with an increase in the population of EV that express MHC class-type antigens typically attributed to dendritic cells and microglia [291]. This evidence concerns the gene HLA-C and Alzheimer disease.